Is the pathobiology of chemotherapy-induced alimentary tract mucositis influenced by the type of mucotoxic drug administered?
- 20 March 2008
- journal article
- research article
- Published by Springer Science and Business Media LLC in Cancer Chemotherapy and Pharmacology
- Vol. 63 (2), 239-251
- https://doi.org/10.1007/s00280-008-0732-8
Abstract
No abstract availableKeywords
This publication has 29 references indexed in Scilit:
- Methotrexate‐induced mucositis in mucin 2‐deficient miceJournal of Cellular Physiology, 2006
- New thoughts on the pathobiology of regimen-related mucosal injurySupportive Care in Cancer, 2006
- Relationship between dose of methotrexate, apoptosis, p53/p21 expression and intestinal crypt proliferation in the ratClinical and Experimental Medicine, 2005
- Pre-treatment with insulin-like growth factor-I partially ameliorates 5-fluorouracil-induced intestinal mucositis in ratsGrowth Hormone & IGF Research, 2005
- Cytotoxic chemotherapy upregulates pro-poptotic Bax and Bak in the small intestine of rats and humansPathology, 2005
- Alanyl-glutamine hastens morphologic recovery from 5-fluorouracil–induced mucositis in miceNutrition, 2004
- The burdens of cancer therapyCancer, 2003
- Methotrexate Suppresses NF-κB Activation Through Inhibition of IκBα Phosphorylation and DegradationPublished by The American Association of Immunologists ,2001
- 5-Fluorouracil Suppression of NF-κB Is Mediated by the Inhibition of IκB Kinase Activity in Human Salivary Gland Cancer CellsBiochemical and Biophysical Research Communications, 2001
- 5-Fluorouracil Induces Apoptosis through the Suppression of NF-κB Activity in Human Salivary Gland Cancer CellsBiochemical and Biophysical Research Communications, 2000